- Home
- RYM vs HOWL Comparison
RYM vs HOWL Comparison
Compare RYM & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYM
- HOWL
- Stock Information
- Founded
- RYM 2016
- HOWL 2017
- Country
- RYM United States
- HOWL United States
- Employees
- RYM N/A
- HOWL N/A
- Industry
- RYM Farming/Seeds/Milling
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- RYM Consumer Staples
- HOWL Health Care
- Exchange
- RYM Nasdaq
- HOWL Nasdaq
- Market Cap
- RYM 75.6M
- HOWL 64.5M
- IPO Year
- RYM 2021
- HOWL 2021
- Fundamental
- Price
- RYM $18.81
- HOWL $0.93
- Analyst Decision
- RYM
- HOWL Strong Buy
- Analyst Count
- RYM 0
- HOWL 5
- Target Price
- RYM N/A
- HOWL $7.00
- AVG Volume (30 Days)
- RYM 21.5K
- HOWL 732.3K
- Earning Date
- RYM 11-07-2025
- HOWL 11-04-2025
- Dividend Yield
- RYM N/A
- HOWL N/A
- EPS Growth
- RYM N/A
- HOWL N/A
- EPS
- RYM N/A
- HOWL N/A
- Revenue
- RYM $16,303,000.00
- HOWL N/A
- Revenue This Year
- RYM N/A
- HOWL N/A
- Revenue Next Year
- RYM N/A
- HOWL N/A
- P/E Ratio
- RYM N/A
- HOWL N/A
- Revenue Growth
- RYM 1338.92
- HOWL N/A
- 52 Week Low
- RYM $13.22
- HOWL $0.60
- 52 Week High
- RYM $84.44
- HOWL $2.38
- Technical
- Relative Strength Index (RSI)
- RYM N/A
- HOWL 24.51
- Support Level
- RYM N/A
- HOWL $0.89
- Resistance Level
- RYM N/A
- HOWL $1.00
- Average True Range (ATR)
- RYM 0.00
- HOWL 0.11
- MACD
- RYM 0.00
- HOWL -0.03
- Stochastic Oscillator
- RYM 0.00
- HOWL 5.58
About RYM RYTHM Inc.
Rythm Inc is a USA Based company. The Company's portfolio of brands delivers well-being to millions of Americans every year. The company features some of the recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, &Shine, Doctor Solomon's and Good Green in thousands of physical locations and online channels. With products rooted in quality, safety, and innovation, the Company is shaping cannabis experiences that enhance daily life.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.